Company / Free Cash Flow per Share
NewAmsterdam Pharma Co N.V. Free Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.25
FY2025
5-year range
-$2.69 / $0.55
FY2021-FY2025
Trend
+25.9%
vs FY2024
Sector context
#112 of 191
Health Care
What the data says
At $-1.25, NewAmsterdam Pharma Co N.V.'s free cash flow per share ranks #112 of 191 in the Health Care sector. Improved from $-1.72 to $-1.25 over the past 2 years.
Based on SEC 10-K filings.
-1.25 in FY2025.
Improved from $-1.72 to $-1.25 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 191 in Health CareTop 59% of 191This company -$1.25 Sector average -$24.68
▼
+94.9% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 25.9% year-over-year.
- Ranks #112 out of 191 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.25 | +25.9% |
| FY2024 | -$1.69 | +1.8% |
| FY2023 | -$1.72 | -412.2% |
| FY2022 | $0.55 | +120.5% |
| FY2021 | -$2.69 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026